We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




North American CT Market Ready for Rebound

By MedImaging staff writers
Posted on 12 Mar 2007
The launch of the new top tier of computed tomography (CT) imaging equipment, particularly 64-slice CT, drove the North American CT imaging equipment market toward double-digit growth rates in 2004 and 2005. More...
New analysis revealed that the CT market earned revenues of US$1.57 billion in 2005 and estimates this to reach US$2.39 billion in 2012.

According to Frost & Sullivan (Palo Alto, CA, USA), an international growth consultancy company, equipment providers will be actively trying to address the challenges brought about by a disruptive technology. Market participants have to ensure workflow enhancements, greater clinical utility of CT, adequate end-user training, and favorable reimbursement updates for wide adoption of future equipment.

"The workflow of personnel along the entire chain of events--from exam ordering to reporting--demands better training, more efficient software, and support of an adequate IT [information technology] infrastructure,” stated Frost & Sullivan research analyst Nadim Daher. "Meanwhile, promising clinical trials and technical work-in-progress hint at yet another revolution in CT.”

The fast pace at which CT technology has evolved has overwhelmed certain end-user segments concerned with the rapid obsolescence of the technology. In the present reimbursement environment, healthcare providers cannot only depend on the exceptional cardiac imaging capabilities of this technology.

Before commercializing more powerful scanners, market participants will have to attempt at further reducing manufacturing costs to offset negative reimbursement trends and guarantee the economical viability of advanced CT purchases, according to Frost & Sullivan.

The development of cardiac CT imaging has revitalized the North American CT market. Going forward, market growth is contingent upon the expansion of CT in this and other specialty imaging areas. In fact, clinicians are eagerly awaiting advances in cardiac and coronary artery imaging.

"Current users of 64-slice CT technology find that image quality has room for improvements, especially its low-contrast resolution for better plaque characterization capabilities,” noted Mr. Daher. "Larger detector coverage and multi-energy imaging will transform advanced CT imaging.”


Related Links:
Frost & Sullivan

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.